CINCINNATI, July 24, 2025 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, today reported financial and operating results for the period ended June 30, 2025 and increased full year 2025 earnings guidance. For the three and six months ended June 30, 2025, net income attributable to stockholders was $12.8 million, or $0.10 per diluted share, and $39.1 m ...

SAN CARLOS, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, will report its second quarter and first half 2025 financial results and corporate updates on Thursday, August 7, 2025. Management will host a conference call and live audio webcast to discuss these results and provide a corporate update on August 7 ...

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Teads Holding Co. (NASDAQ: TEAD), announced today that the company will release its second quarter 2025 results before the market opens on Thursday, August 7, 2025, followed by a conference call at 8:30 a.m. (Eastern Time) that same day to discuss the company’s results and business outlook. The conference call can be accessed live over the phone by dialing 1-888-437-3179 or for international callers, 1-862-298-0702. A replay will be available two hours after the c ...

REDWOOD CITY, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the publication of a peer-reviewed research paper in Science. The scientific paper details the discovery and development of zoldonrasib (RMC-9805), a RAS(ON) G12D-selective covalent inhibitor. Oncogenic RAS mutations are observed in approximately 92% of pancreatic ductal adenocarcinoma ( ...

SOUTH SAN FRANCISCO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report second quarter results on August 7, 2025 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics’ senior management will host a conference call at 4:30 PM Eastern Time to discuss financial results and provide business updates. The conference call will be simultaneously webcast and can be accessed from the Investors & Media section of Cytokinetics’ ...

Group 1 - The Board of Directors of Provident Financial Services, Inc. declared a quarterly cash dividend of $0.24 per common share, payable on August 29, 2025, to stockholders of record as of the close of business on August 15, 2025 [1] Group 2 - Provident Financial Services, Inc. is the holding company for Provident Bank, which has been providing community-oriented banking services since 1839 [2] - Provident Bank offers a comprehensive array of financial products and services through its branches located in New Jersey, Bucks, Lehigh, and Northampton counties in Pennsylvania, as well as Orange, Queens, and Nassau Counties in New York [2] - The Bank also provides fiduciary and wealth management services through its subsidiary, Beacon Trust Company, and insurance services through its subsidiary, Provident Protection Plus, Inc. [2]

HONG KONG, July 24, 2025 (GLOBE NEWSWIRE) -- Dreamland Limited (Nasdaq: TDIC) (the “Company” or “Dreamland”), a Hong Kong-based event management service provider, today announced the closing of its initial public offering (the “Offering”) of 2,000,000 Class A ordinary shares, 1,340,000 of which were offered by the Company and 660,000 by an existing shareholder (the “Selling Shareholder”), at a public offering price of US$4.00 per Class A ordinary share. The Company also filed a resale prospectus concurrent ...

Core Viewpoint - Garden Stage Limited has entered into a definitive agreement for a registered direct offering of 38,406,345 ordinary shares at a price of $0.11 per share, expected to raise approximately $4.2 million in gross proceeds [1][2]. Group 1: Offering Details - The offering includes the option for pre-funded warrants at the same price, with an exercise price of $0.001 per share [1]. - The transaction is anticipated to close on or about July 25, 2025, pending customary closing conditions [2]. - The offering is conducted under a shelf registration statement previously filed and declared effective by the SEC [3]. Group 2: Company Overview - Garden Stage Limited is a Hong Kong-based financial services provider engaged in placing and underwriting services, securities dealing and brokerage, asset management, and investment advisory services [5]. - The company operates through wholly-owned subsidiaries, including I Win Securities Limited and I Win Asset Management Limited, both licensed for various regulated activities under Hong Kong's SFO [5].

TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- (TSX: BAAA, BAAA.U) Brompton Wellington Square AAA CLO ETF announces distributions payable on August 15, 2025 to unitholders of record at the close of business on July 31, 2025 as follows: TickerAmount Per UnitBAAA Cdn$0.08960BAAA.U US$0.08950 About Brompton FundsFounded in 2000, Brompton is an experienced investment fund manager with income and growth focused investment solutions including TSX traded closed-end funds and exchange-traded funds. For further informa ...

Solid results in the first half of 2025despite the prevailing environment. Revenue: €40 billion. Profit from recurring operations: €9 billion. Free cash flow: €4 billion Paris, July 24, 2025 The Christian Dior Group recorded revenue of €39.8 billion in the first half of 2025. The Group showed good resilience and maintained its powerful innovative momentum despite a disrupted geopolitical and economic environment.Local demand was solid in Europe, which achieved growth on a constant consolidation scope and cu ...